Search - tctmd.com

Displaying 541 - 560 of 648

Sort: Relevancy | Date

LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY

Presentation TCT 2013

LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY

Presenter: Francesco Burzotta, Pan Manuel, Trani Carlo, Medina Alfonso, SU?REZ DE LEZO Jos?, Niccoli Giampaolo, Romero Miguel, Porto Italo, Mazuelos Francisco, Leone Antonio Maria, Martin Pedro, Valentina Coluccia, SU?REZ DE LEZO Javier, OJEDA Soledad, Crea Filippo

January 31, 2013

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

Update on the Commercial Launch of TAVR in the United States: Site Selection, Training, Clinical Indications, Case Volumes, and Clinical Outcomes

Presentation TCT 2012

Update on the Commercial Launch of TAVR in the United States: Site Selection, Training, Clinical Indications, Case Volumes, and Clinical Outcomes

Presenter: Martin Leon

October 26, 2012

Presentation TCT 2012

The Odyssey of Transcatheter Aortic Valve Replacement (TAVR): From Concept to Clinical Reality: A 10-Year Anniversary Celebration

Presenter: Martin Leon

October 26, 2012

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

TCT 2012 Career Achievement Award: Renu Virmani

Presentation TCT 2012

TCT 2012 Career Achievement Award: Renu Virmani

Presenter: Martin B. Leon

October 25, 2012

Valve Medical TAVR System

Presentation TCT 2012

Valve Medical TAVR System

Presenter: Martin Leon

October 24, 2012

Novel Transapical Left Ventricular Access and Closure Devices

Presentation TCT 2012

Novel Transapical Left Ventricular Access and Closure Devices

Presenter: Martin Leon

October 24, 2012

News Conference News TCT 2012

DES: The Year in Review

October 23, 2012

Update from the Randomized PARTNER 2A Trial

Presentation TCT 2012

Update from the Randomized PARTNER 2A Trial

Presenter: Martin Leon

October 22, 2012

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

Presentation TCT 2012

Evidence/Practice Intersection: What We Know, What We Don't, and How to Treat

Presenter: Martin Leon

October 22, 2012

DES the Year in Review: Trends, Utilization, Science, and Controversies

Presentation TCT 2012

DES the Year in Review: Trends, Utilization, Science, and Controversies

Presenter: Martin Leon

October 22, 2012

Dedicated Bifurcation Stents: Tryton Program Update

Presentation TCT 2012

Dedicated Bifurcation Stents: Tryton Program Update

Presenter: Martin Leon

October 22, 2012

Clinical Outcomes and Complications

Presentation TCT 2012

Clinical Outcomes and Complications

Presenter: Martin Leon

October 22, 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presentation TCT 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presenter: Martin Leon

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Conference News ESC 2012

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

August 26, 2012

News Daily News

PARTNER Analysis: Vascular Complications Common in Transfemoral TAVR

August 14, 2012

News Daily News

Análisis del ensayo PARTNER: Las Complicaciones Vasculares son Frecuentes en la TAVR Transfemoral

August 14, 2012

TAVR 2012: Next Generation Valves and Ancillary Devices

Presentation ACVS 2012

TAVR 2012: Next Generation Valves and Ancillary Devices

Presenter: Martin B. Leon

August 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.